Laddar...
Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
BACKGROUND: The high lifetime risk of vascular disease is one of the important issues that plague patients with diabetes mellitus. Systemic oral vildagliptin administration favors endothelial recovery and inhibits smooth muscle cell (SMC) proliferation. However, the localized release of vildagliptin...
Sparad:
| I publikationen: | Int J Nanomedicine |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6751553/ https://ncbi.nlm.nih.gov/pubmed/31686818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S211898 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|